Leiden University Medical Center, Department of Rheumatology, C1-R, Albinusdreef 2, Leiden, The Netherlands.
Nat Rev Rheumatol. 2010 Feb;6(2):68-70. doi: 10.1038/nrrheum.2009.253.
Since the introduction of new biologic agents and intensive treatment strategies that aim to tightly control disease activity, clinical remission has become a realistic target in patients with rheumatoid arthritis. Once patients are in continuous remission, however, is it realistic to consider withdrawing DMARD therapy?
自从引入旨在严格控制疾病活动的新型生物制剂和强化治疗策略以来,类风湿关节炎患者的临床缓解已成为现实目标。然而,一旦患者持续缓解,是否可以考虑停用 DMARD 治疗?